Adaptive Biotechnologies
ADPT • NASDAQ
Adaptive Biotechnologies is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Chad Robins, with a market cap of $2.1B.
Market Cap$2.1B
Employees709.0
CEOChad Robins
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsApr 30, 2026 · In 2 weeksQ1 2026
Financials
Adaptive Biotechnologies FAQ
Common questions about Adaptive Biotechnologies
Adaptive Biotechnologies is scheduled to report earnings for Q1 2026 on April 30, 2026. Analysts estimate revenue of $61.3M.
Adaptive Biotechnologies has approximately 709 employees.